Summary

The global medical device contract manufacturing market is projected to reach 149.4 Billion in 2029 from USD 78.9 Billion in 2023, at a CAGR of 11.4% between 2024 and 2029.
The market is anticipated to grow as a result of development continuous advancements in medical devices felid such as robotics and minimally invasive surgery, artificial intelligence (AI) in medical devices, telemedicine and remote patient monitoring is expected to drive the market growth.
Ageing populations with rising need for medical diagnostics further contribute to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.

“Based on the device type, the cardiovascular device segment is expected to grow by the highest CAGR in the medical device contract manufacturing market.”
Devices like pacemakers regulate irregular heartbeats, stents open blocked arteries, and defibrillators prevent sudden cardiac arrest. This translates to a reduced risk of mortality and improved cardiovascular health also advancements in technologies like balloon angioplasty and stent placement allow for less invasive procedures compared to traditional open-heart surgery. This leads to quicker recovery times, reduced pain, and minimized scarring which is expected to drive the market growth.

“The device and component manufacturing services segment is expected to grow with the highest CAGR in the device development and manufacturing services segment in the medical device contract manufacturing market.”
Device and component manufacturing services offer several significant advantages which includes reduced costs, contract manufacturers (CMs) specialize in high-volume production, allowing them to leverage economies of scale and negotiate better rates with material suppliers. This translates to cost savings for medical device companies that may not have the resources to establish their own large-scale manufacturing facilities.

“Based on the class of device, the class III segment is expected to grow by the highest CAGR in the medical device contract manufacturing market. Out of the other class of device, class III is expected to grow at the highest CAGR from 2024 to 2029.”
The stringent regulatory requirements for class III devices incentivize manufacturers to invest heavily in research and development. This leads to continuous innovation and the creation of new, more sophisticated medical technologies that push the boundaries of healthcare possibilities which is expected to drive the medical device contract manufacturing market.

“Asia-Pacific to grow with the highest CAGR in the medical device contract manufacturing market during the forecast period.”
The rapid population growth, increasing awareness about medical devices, and a rising middle class translate to a strong demand for MDCM services across Asia Pacific. Also global leaders in medical device contract manufacturing are establishing their presence in APAC, introducing advanced devices, innovative software, and diverse biocompatible materials.
Europe was the largest segment in the medical device contract manufacturing market in 2023. The Germany accounted for the larger share of the European medical device contract manufacturing market in 2023. The rising number of chronic diseases and and growing awareness regarding medical devices is expected to drive the market growth in Europen market.

A breakdown of the primary participants (supply-side) for the medical device contract manufacturing market referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
• By Designation: C-level–30%, Director Level–55%, and Others–15%
• By Region: North America–20%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East & Africa-30%.

Prominent players in the medical device contract manufacturing market include Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corp. (US), Integer Holdings Corporation (US), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), Carclo Plc (UK), Nolato GW, Inc. (US), MeHow (China), Tekni-Plex (US), and Peter’s Technology (China).

Research Coverage:
The report analyzes the medical device contract manufacturing market and aims at estimating the market size and future growth potential of this market based on various segments such as device type, class of device, service and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical device contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
 Analysis of key drivers (growth in medical devices market in developing countries, adoption of robotics and automation in manufacturing processes, technological advancements in medical device modalities, impact of industry 4.0 on the medical device industry), restraints (consolidation in medical devices market by acquiring small and medium-sized companies), opportunities (increasing healthcare expenditure, infrastructure, and awareness in developing countries, rising geriatric population and its associated diseases) and challenges (lack of constant innovation to balance technological capabilities against costs)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global medical device contract manufacturing market. The report includes various segments in market device type, class of device, service and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical device contract manufacturing market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by device type, class of device, service and region
• Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global medical device contract manufacturing market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global medical device contract manufacturing market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 52
1.1 STUDY OBJECTIVES 52
1.2 MARKET DEFINITION 52
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
1.3.2 REGIONS COVERED 54
1.3.3 YEARS CONSIDERED 54
1.3.4 CURRENCY CONSIDERED 55
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 55
1.4 STAKEHOLDERS 55
1.5 SUMMARY OF CHANGES 55
1.5.1 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 1 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 58
2.1.1.1 Key data from secondary sources 59
2.1.2 PRIMARY DATA 60
FIGURE 2 PRIMARY SOURCES 60
2.1.2.1 Key data from primary sources 61
2.1.2.2 Key industry insights 62
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 62
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 63
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 63
2.2 MARKET SIZE ESTIMATION 64
FIGURE 6 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 64
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD. 65
FIGURE 8 SUPPLY-SIDE ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2023) 66
FIGURE 9 DEMAND-SIDE ESTIMATION FOR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 67
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 68
FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 68
FIGURE 12 TOP-DOWN APPROACH 69
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 70
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 70
2.4 MARKET SHARE ESTIMATION 70
2.5 STUDY ASSUMPTIONS 71
2.6 RESEARCH LIMITATIONS 71
2.6.1 METHODOLOGY-RELATED LIMITATIONS 71
2.6.2 SCOPE-RELATED LIMITATIONS 71
2.7 RISK ASSESSMENT 72
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 72
2.8 RECESSION IMPACT ANALYSIS 72
3 EXECUTIVE SUMMARY 73
FIGURE 14 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2024 VS. 2029 (USD MILLION) 73
FIGURE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2024 VS. 2029 (USD MILLION) 74
FIGURE 16 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION) 75
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 76
4 PREMIUM INSIGHTS 77
4.1 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET OVERVIEW 77
FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET 77
4.2 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE AND COUNTRY (2023) 78
FIGURE 19 CLASS III MEDICAL DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023 78
4.3 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 79
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 79
4.4 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80
FIGURE 21 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 80
4.5 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: REGIONAL MIX 81
FIGURE 22 ASIA PACIFIC WILL CONTINUE TO DOMINATE MARKET IN 2029 81
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
FIGURE 23 MARKET DYNAMICS: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 82
5.2.1 DRIVERS 83
5.2.1.1 Growing medical devices market in developing countries 83
TABLE 3 GDP GROWTH FORECAST: COMPARISON OF INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST) 83
5.2.1.2 Adoption of robotics and automation in manufacturing 84
5.2.1.3 Technological advancements in medical device modalities 85
FIGURE 24 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING 86
5.2.1.4 Impact of Industry 4.0 on medical device industry 86
5.2.2 RESTRAINTS 87
5.2.2.1 Consolidation in medical devices market 87
TABLE 4 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY 87
5.2.3 OPPORTUNITIES 88
5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing economies 88
TABLE 5 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021) 88
TABLE 6 HEALTHCARE EXPENDITURE PER CAPITA (USD),(2015 AND 2050) 89
5.2.3.2 Rising geriatric population and increasing incidence of associated diseases 89
TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050 89
TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST) 90
5.2.4 CHALLENGES 90
5.2.4.1 Lack of constant innovation to balance technological capabilities against costs 90
5.2.5 INDUSTRY TRENDS 91
5.2.5.1 Increasing consolidation of OEMs and contract manufacturers 91
TABLE 9 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST FIVE YEARS 91
TABLE 10 KEY EXAMPLES OF CMO CONSOLIDATION 91
5.2.5.2 Growing interest of private equity firms in medical device contract manufacturing 92
TABLE 11 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS 92
5.2.5.3 Outsourcing of medical device contract manufacturing services 93
TABLE 12 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS 93
5.2.6 INDUSTRY 5.0 93
5.3 PRICING ANALYSIS 94
5.3.1 AVERAGE SELLING PRICE TREND FOR MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES, BY DEVICE 94
TABLE 13 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY DEVICE 94
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 95
TABLE 14 AVERAGE COST RANGE OF MEDICAL DEVICE CONTRACT MANUFACTURING PRODUCTS, 2023 (USD) 95
5.4 VALUE CHAIN ANALYSIS 96
FIGURE 25 VALUE CHAIN ANALYSIS: MEDICAL DEVICE CONTRACT MANUFACTURING (2023) 96
5.5 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 15 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.5.1 THREAT OF NEW ENTRANTS 97
5.5.1.1 Growth in medical device industry 97
5.5.1.2 Demand for compact, cost-effective, and non-invasive devices 97
5.5.1.3 Consolidation 97
5.5.1.4 Poor financing environment 97
5.5.1.5 Stringent regulatory environment 98
5.5.2 THREAT OF SUBSTITUTES 98
5.5.2.1 Undesirability of existing portfolios 98
5.5.2.2 Combination and integration of multiple technologies 98
5.5.2.3 Availability of alternatives 98
5.5.3 BARGAINING POWER OF SUPPLIERS 98
5.5.3.1 Big medical device contract manufacturing companies 98
5.5.3.2 Institutional technology providers 98
5.5.3.3 Substantially innovative technologies 99
5.5.3.4 Dysfunctional companies 99
5.5.3.5 Academic inventors 99
5.5.4 BARGAINING POWER OF BUYERS 99
5.5.4.1 Few buyers and many sellers 99
5.5.4.2 Buy-out threat 99
5.5.4.3 Demand for new pipeline services 99
5.5.4.4 Point of differentiation 99
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.5.5.1 Similar spectrum of services offered 100
5.5.5.2 Similar funding source 100
5.5.5.3 Self-funded big contract manufacturers 100
5.5.5.4 Highly fragmented industry 100
5.6 TARIFF AND REGULATORY LANDSCAPE 100
5.6.1 REGULATORY ANALYSIS 100
5.6.1.1 North America 100
5.6.1.1.1 US 100
TABLE 16 US: CLASSIFICATION OF MEDICAL EQUIPMENT 100
TABLE 17 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 101
5.6.1.1.2 Canada 101
TABLE 18 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 101
5.6.1.2 Europe 102
TABLE 19 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 102
5.6.1.3 Asia Pacific 102
5.6.1.3.1 Japan 102
TABLE 20 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 103
5.6.1.3.2 China 103
TABLE 21 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 103
5.6.1.3.3 India 104
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
5.7 KEY CONFERENCES AND EVENTS, 2024–2025 107
TABLE 27 DETAILED LIST OF CONFERENCES AND EVENTS 107
5.8 PATENT ANALYSIS 108
5.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES 108
FIGURE 26 PATENT PUBLICATION TRENDS (JANUARY 2013–NOVEMBER 2023) 108
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 108
FIGURE 27 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023) 109
FIGURE 28 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICE PATENTS (JANUARY 2013–NOVEMBER 2023) 109
TABLE 28 MEDICAL DEVICES: LIST OF MAJOR PATENTS 110
5.9 TECHNOLOGY ANALYSIS 111
5.9.1 KEY TECHNOLOGIES 111
5.9.1.1 Digital transformation 111
5.9.1.2 Robotics and automation 111
5.9.2 ADJACENT TECHNOLOGIES 112
5.9.2.1 Artificial Intelligence 112
5.9.2.2 Big data 112
5.9.3 COMPLEMENTARY TECHNOLOGIES 112
5.9.3.1 5G 112
5.10 SUPPLY CHAIN ANALYSIS 113
FIGURE 29 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2023) 113
5.11 ECOSYSTEM ANALYSIS 113
TABLE 29 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023 113
FIGURE 30 ROLE IN ECOSYSTEM: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2023 114
5.12 TRADE ANALYSIS 115
TABLE 30 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023 115
TABLE 31 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2023 115
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 116
FIGURE 31 REVENUE SHIFTS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 116
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 116
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 116
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 116
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES 117
5.14.2 BUYING CRITERIA 117
FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES 117
TABLE 33 KEY BUYING CRITERIA FOR MEDICAL DEVICES 117
5.15 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 118
FIGURE 34 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 118
5.16 UNMET NEEDS/END-USER EXPECTATIONS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 118
5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 119
5.18 CASE STUDY ANALYSIS 119
5.18.1 JABIL INC. AND HEARTWARE INTERNATIONAL 119
5.18.2 FLEX LTD. IN MEDICAL DEVICE MANUFACTURING 120
5.18.3 BRINGING AN INNOVATIVE INSULIN PUMP TO MARKET 120
5.19 INVESTMENT AND FUNDING SCENARIO 121
TABLE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, 2018–2022 121
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 122
6.1 INTRODUCTION 123
TABLE 35 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 123
6.2 IVD DEVICES 124
TABLE 36 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 124
TABLE 37 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 125
6.2.1 IVD CONSUMABLES 126
6.2.1.1 Increasing demand for reagents & kits to drive market 126
TABLE 38 IVD CONSUMABLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 127
6.2.2 IVD EQUIPMENT 127
6.2.2.1 Advances in life sciences research to support market growth 127
TABLE 39 IVD EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 128
6.3 DIAGNOSTIC IMAGING DEVICES 129
6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 129
TABLE 40 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 130
6.4 CARDIOVASCULAR DEVICES 131
6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET 131
TABLE 41 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035 131
TABLE 42 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 132
6.5 DRUG DELIVERY DEVICES 133
TABLE 43 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 133
TABLE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 134
6.5.1 INFUSION DEVICES & ADMINISTRATION SETS 135
6.5.1.1 Rising incidence of chronic diseases to fuel market growth 135
TABLE 45 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 136
6.5.2 SYRINGES 137
6.5.2.1 Increasing incidence of needlestick injuries to hamper market growth 137
TABLE 46 SYRINGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
6.5.3 INHALERS 139
6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market growth 139
TABLE 47 INHALERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 140
6.5.4 AUTOINJECTORS & PEN INJECTORS 141
6.5.4.1 Rising number of regulatory approvals for new drug therapies to support market growth 141
TABLE 48 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY 141
TABLE 49 AUTOINJECTORS & PEN INJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 142
6.6 ORTHOPEDIC DEVICES 143
6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET 143
TABLE 50 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 144
6.7 RESPIRATORY CARE DEVICES 145
6.7.1 COVID-19 BOOSTED DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES 145
TABLE 51 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 146
6.8 OPHTHALMOLOGY DEVICES 147
6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET 147
TABLE 52 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 148
6.9 SURGICAL DEVICES 149
6.9.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO FUEL MARKET GROWTH 149
TABLE 53 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 150
6.10 DIABETES CARE DEVICES 151
6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET 151
TABLE 54 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045 151
TABLE 55 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 152
6.11 DENTAL DEVICES 153
6.11.1 RISING INCIDENCE OF DENTAL DISORDERS TO SUPPORT MARKET GROWTH 153
TABLE 56 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DENTAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 154
6.12 ENDOSCOPY & LAPAROSCOPY DEVICES 155
6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET 155
TABLE 57 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR ENDOSCOPY & LAPAROSCOPY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 156
6.13 GYNECOLOGY/UROLOGY DEVICES 157
6.13.1 GROWING AWARENESS AND PREVENTIVE CHECKUPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET 157
FIGURE 35 US: SEXUALLY TRANSMITTED DISEASE CASES, 2017 VS. 2021 157
TABLE 58 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR GYNECOLOGY/UROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 158
6.14 PERSONAL CARE DEVICES 159
6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET 159
TABLE 59 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 160
6.15 NEUROLOGY DEVICES 161
6.15.1 RISING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE MARKET 161
TABLE 60 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 162
6.16 PATIENT MONITORING DEVICES 163
6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET 163
TABLE 61 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 164
6.17 PATIENT ASSISTIVE DEVICES 165
6.17.1 RISING GERIATRIC POPULATION TO PROPEL MARKET 165
TABLE 62 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 166
6.18 OTHER DEVICES 167
TABLE 63 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 167
7 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE 168
7.1 INTRODUCTION 169
TABLE 64 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 169
7.2 COMPARISON OF DEVICE CLASSIFICATION, BY COUNTRY/REGION 169
7.2.1 US 169
7.2.1.1 Class I: General controls 169
7.2.1.2 Class II: General controls with special controls 169
7.2.1.3 Class III: General controls, special controls, and premarket approval 170
7.2.2 CANADA 170
7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION 170
7.2.3.1 Class I medical devices 170
7.2.3.1.1 Class Is: Noninvasive devices 171
7.2.3.1.2 Class Ir: Reusable surgical instruments 171
7.2.3.1.3 Class Im: Low-risk measuring devices 171
7.2.3.2 Class IIa medical devices 171
7.2.3.3 Class IIb medical devices 171
7.2.3.4 Class III medical devices 171
7.2.4 ASIA PACIFIC 172
7.2.4.1 China 172
7.2.4.2 India 172
7.2.4.3 Japan 173
7.2.4.4 Australia 173
7.3 CLASS II MEDICAL DEVICES 174
7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET GROWTH 174
TABLE 65 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 175
7.4 CLASS I MEDICAL DEVICES 176
7.4.1 POSSESS MINIMUM POTENTIAL TO HARM USERS 176
TABLE 66 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 177
7.5 CLASS III MEDICAL DEVICES 178
7.5.1 INVOLVE HIGHEST LEVEL OF HEALTH RISKS TO USERS 178
TABLE 67 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2021–2029 (USD MILLION) 179
8 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE 180
8.1 INTRODUCTION 181
FIGURE 36 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES 181
TABLE 68 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 181
8.2 DEVICE DEVELOPMENT AND MANUFACTURING 182
TABLE 69 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 182
TABLE 70 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 183
8.2.1 DEVICE AND COMPONENT MANUFACTURING 184
8.2.1.1 Development of new technologies necessitates specialized device manufacturing capabilities 184
TABLE 71 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 185
8.2.2 PROCESS DEVELOPMENT 186
8.2.2.1 Growing demand for complex products to drive growth 186
FIGURE 37 PROCESS DEVELOPMENT SERVICES FOR MEDICAL DEVICES 186
TABLE 72 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 188
8.2.3 DEVICE ENGINEERING 189
8.2.3.1 Efficiency and cost-effectiveness of device engineering services to propel segment 189
TABLE 73 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 190
8.3 QUALITY MANAGEMENT 191
TABLE 74 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 191
TABLE 75 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 192
8.3.1 PACKAGING VALIDATION 193
8.3.1.1 Increasing product safety concerns for medical devices to aid market 193
TABLE 76 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 193
8.3.2 INSPECTION AND TESTING 194
8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments 194
TABLE 77 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 195
8.3.3 STERILIZATION SERVICES 196
8.3.3.1 Need to meet regulatory requirements for sterility in medical devices to support market growth 196
TABLE 78 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE 196
TABLE 79 STERILIZATION SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 197
8.4 PACKAGING AND ASSEMBLY SERVICES 198
FIGURE 38 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES 198
TABLE 80 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 198
TABLE 81 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 199
8.4.1 PRIMARY AND SECONDARY PACKAGING 200
8.4.1.1 Growing concerns for patient safety to aid growth 200
TABLE 82 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 200
8.4.2 LABELING 201
8.4.2.1 Export bans and product recalls due to improper labeling to support market 201
TABLE 83 LABELING SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 201
8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES 202
TABLE 84 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 202
8.5 OTHER SERVICES 203
TABLE 85 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR OTHER SERVICES, BY COUNTRY, 2021–2029 (USD MILLION) 203
9 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION 204
9.1 INTRODUCTION 205
FIGURE 39 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 205
TABLE 86 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2029 (USD MILLION) 206
9.2 ASIA PACIFIC 206
9.2.1 ASIA PACIFIC: RECESSION IMPACT 206
FIGURE 40 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SNAPSHOT 207
TABLE 87 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 208
TABLE 88 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 209
TABLE 89 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 209
TABLE 90 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 210
TABLE 91 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 210
TABLE 92 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 211
TABLE 93 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 211
TABLE 94 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 212
TABLE 95 ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 212
9.2.2 CHINA 212
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market 212
TABLE 96 CHINA: KEY MACROINDICATORS 213
TABLE 97 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 214
TABLE 98 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 214
TABLE 99 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 215
TABLE 100 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 215
TABLE 101 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 216
TABLE 102 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 216
TABLE 103 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 217
TABLE 104 CHINA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 217
9.2.3 JAPAN 217
9.2.3.1 Universal healthcare reimbursement policies to propel market 217
TABLE 105 JAPAN: KEY MACROINDICATORS 218
TABLE 106 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 219
TABLE 107 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 219
TABLE 108 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 220
TABLE 109 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 220
TABLE 110 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 221
TABLE 111 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 112 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 222
TABLE 113 JAPAN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 222
9.2.4 MALAYSIA & SINGAPORE 222
9.2.4.1 Increasing R&D activities and investments by established players to augment market 222
TABLE 114 MALAYSIA: KEY MACROINDICATORS 223
TABLE 115 SINGAPORE: KEY MACROINDICATORS 223
TABLE 116 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 224
TABLE 117 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 224
TABLE 118 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 225
TABLE 119 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 225
TABLE 120 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 226
TABLE 121 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 226
TABLE 122 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 227
TABLE 123 MALAYSIA & SINGAPORE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 227
9.2.5 INDIA 227
9.2.5.1 Rising contract manufacturing capabilities to support market growth 227
TABLE 124 INDIA: KEY MACROINDICATORS 228
TABLE 125 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 229
TABLE 126 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 229
TABLE 127 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 230
TABLE 128 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 230
TABLE 129 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 231
TABLE 130 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 231
TABLE 131 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 232
TABLE 132 INDIA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 232
9.2.6 AUSTRALIA & NEW ZEALAND 232
9.2.6.1 Need for advanced medical and diagnostic tools to fuel market growth 232
TABLE 133 AUSTRALIA: KEY MACROINDICATORS 233
TABLE 134 NEW ZEALAND: KEY MACROINDICATORS 233
TABLE 135 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 234
TABLE 136 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 234
TABLE 137 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 235
TABLE 138 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 235
TABLE 139 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 236
TABLE 140 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 236
TABLE 141 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 142 AUSTRALIA & NEW ZEALAND: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 237
9.2.7 SOUTH KOREA 237
9.2.7.1 High-value imports from other countries to offer growth opportunities 237
TABLE 143 SOUTH KOREA: KEY MACROINDICATORS 238
TABLE 144 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 238
TABLE 145 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 146 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 147 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 239
TABLE 148 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 240
TABLE 149 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 150 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 241
TABLE 151 SOUTH KOREA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 241
9.2.8 REST OF ASIA PACIFIC 241
TABLE 152 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 242
TABLE 153 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 242
TABLE 154 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 243
TABLE 155 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 243
TABLE 156 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 244
TABLE 157 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 158 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 159 REST OF ASIA PACIFIC: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 245
9.3 NORTH AMERICA 246
9.3.1 NORTH AMERICA: RECESSION IMPACT 246
TABLE 160 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 246
TABLE 161 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2029 (USD MILLION) 247
TABLE 162 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR IVD DEVICES, BY TYPE, 2021–2029 (USD MILLION) 247
TABLE 163 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2021–2029 (USD MILLION) 248
TABLE 164 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY CLASS OF DEVICE, 2021–2029 (USD MILLION) 248
TABLE 165 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2029 (USD MILLION) 249
TABLE 166 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 167 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 168 NORTH AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2021–2029 (USD MILLION) 250